Daniel Lavery

Daniel Lavery

Company: Loulou Foundation

Job title: Chief Scientific Officer


Outlining Recent Advances in Disease Pathophysiology 3:00 pm - 6:00 pm

While there are currently no disease modifying therapies for CDKL5, our Workshop Leaders: disease understanding is advancing. From pathophysiology to CDLK5 function and associated signal transduction pathways, this workshop will share pre-clinical developements and explore novel research models to advance your knowledge and expertise one step closer to the clinic. This workshop will cover: Exploring…Read more

day: Pre-Conference Workshop Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.